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indicates the activation of wnt/β-catenin in both tissues. Wnt-1 in-
duced signaling protein (WISP1), a protein downstream canonical
wnt signaling, was highly expressed in the synovium as well, again
indicating activation of this pathway. To determine whether canon-
ical wnt expression in the synovium has the potency to cause
cartilage damage, the canonical wnt wnt8a was overexpressed
speciﬁcally in the synovium by intra-articular injection of an ade-
noviral vector. At day 1 and 3, no signiﬁcant differences were
observed in the cartilage from wnt8 overexpressing knee joints
compared to joints transfected with control virus. Remarkably, at
day 7, a strong induction of cartilage pathology was observed at
the medial margin of the medial tibial plateau (Figure 1), a pref-
erential site for the start of cartilage damage in our models. This
shows that expression of canonical wnt in the synovium causes
cartilage degeneration.
Due to their size, wnt proteins and WISP1 can reach the chon-
drocytes in the cartilage matrix and may alter the chondrocyte
phenotype. Overexpression of wnt8, wnt16 and WISP1 in human
chondrocytes led to the a signiﬁcant increase within 14 days of
Collagen type I, and a signiﬁcant decrease of Collagen type II,
suggesting degeneration of the chondrocyte phenotype.
Figure 1. Focal OA-like cartilage degradation on the medial tibia after 7 days
over-expression of wnt8a (B) in murine knee joints. Control virus did not induce
pathology (A).
Conclusions: Canonical wnt expression and subsequent WISP1
is increased in the synovium during experimental OA. This synovial
expression may lead to the degradation of cartilage, possible
by dedifferentiation of the articular chondrocyte phenotype. This
indicates synovial wnt expression as a potential target for OA
therapy.
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Purpose: Recent studies that have examined the relationship
between body composition and cartilage structure indicate that
metabolic factors associated with adiposity may contribute to the
development and the progression of osteoarthritis (OA). Among
adipose-derived proteins, namely adipokines, leptin has been iden-
tiﬁed as an important factor able to modulate chondrocyte func-
tions. Although the physiological activity of leptin is to reduce food
intake, obesity is characterized by an elevated systemic level of
leptin which fails to decrease body weight, suggesting a leptin
resistance in obese individuals. The current study has been there-
fore undertaken to determine whether hyperleptinemia found in
the joint from obese OA patients induces also a defect in the
action of leptin in chondrocyte.
Methods: Chondrocytes isolated from OA patients with various
BMI ranging from 22 to 47 kg/m2 were treated with 100 or 500
ng/ml of leptin. The expression of cartilage-speciﬁc components
(aggrecan, type 2 collagen), as well as regulating factors (IGF-1,
TGFβ, MMP-13, TIMP 2), was investigated by quantitative real-
time PCR to evaluate chondrocyte responsivness to leptin.
Results: Addition of leptin to human OA chondrocytes up-
regulates the expression of the genes encoding cartilage-speciﬁc
components and regulating factors. However, the effect of the
adipokine was shown to be strongly dependent on the concentra-
tion and the BMI of the patients. When both groups of OA patients
were compared, chondrocytes obtained from normal or overweight
patients (BMI30 kg/m2). Based on this BMI-dependent leptin dose-
response of chondrocytes, we demonstrated that the stimulating
effect of leptin at 100 ng/ml was negatively related with the BMI
of the patients while a positive association between chondrocyte
responsivness and BMI was found at 500 ng/ml of leptin. Beside,
the growth factor induced by leptin was also dependent on BMI.
IGF-1 was up-regulated in chondrocytes collected from normal or
overweight patients while mRNA level of TGFβ was increased in
leptin-treated chondrocytes provided by obese patients. Moreover,
the gene encoding MMP-13 was identiﬁed as a target of leptin for
chondrocytes originated from obese patients only.
Conclusions: The current study showed that the BMI of OA
patients changed the leptin dose-response of chondrocytes and
indicated that chondrocytes from obese patients required elevated
levels of leptin to be responsive. In addition, the BMI-dependent
effect of leptin for the expression of growth factors and MMP-13
suggests that the adipokine may contribute to the fast progression
of OA in obese individuals.
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Purpose: Toll-like receptors (TLR) are the major mediators of the
innate immune response. In monocytes, macrophages and den-
dritic cells, the major effector cells, the primary response to TLR
activation is the induction of inﬂammatory cytokines, chemokines
and a varitety of matricellular proteins, which have been implicated
in wound healing and tissue repair. In articular cartilage TLR ac-
tivation, particularly that of TLR2, leads to expression of matrix
metalloproteases and thus may contribute to cartilage erosion in
osteoarthritis. However, the complete secretome of articular chon-
drocytes in response to TLR ligands has not been characterized.
The purpose of this study was to analyse the proteins induced
following activation of TLR2 and to determine if some of these
components were present in human articular cartilage with early
degenerative changes.
Methods:Human chondrocytes were exposed for 24 h to the TLR2
ligand peptidoglycan or TNF-α. Secreted proteins were analysed
by mass spectrometry. The cytokine proﬁle was analysed using
a cytokine array. In addition, TNF-α levels in culture media were
determined by Elisa assay. Induction of MMP3, MMP13, the Chi-
lectins Chi3L1 and 2, and complement component C3 was further
analysed by western blotting. Cartilage harvested from patients
undergoing joint replacement (n=35, age range: 69 to 101 years
old, 31 females, 4 males). following femoral neck fracture was
extracted with guanidine. and e Extracts were analysed by western
blotting for the presence of Chi3L1 and Chi3L2, and their levels
were quantitated densitometrically and normalized to standards of
puriﬁed protein included in each gel.
Results: Stimulation with the TLR2 ligand peptidoglycan led to
increased production of the matrix metalloproteases MMP3 and
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13 as well as components of the innate stress response, including
the chi-lectins Chi3L1 and Chi3L2 and complement component
C3. The major cytokines present were IL-6, GRO, Rantes and
MCP-1. Neither IL-1 nor TNF-α was detectable. Several stress
response proteins, such as the complement components C1r, C1s
and factor H, clusterin, nucleobindin, the chi-lectin Chi3L1 and
EDA-domain containing ﬁbronectin were detectable both in control
media and following activation of TLR2. Peptidoglycan, TNF-α and
IL-1 induced secretion of Chi3L2, the second member of the hu-
man chi-lectin family. Chi3L2 was not detectable in control media.
Both Chi3L1 and Chi3L2 were present in cartilage from asymp-
tomatic individuals. In contrast to Chi3L1, Chi3L2 levels correlated
with the presence of macroscopic signs of damage (Fig. 1).
Figure 1. Expression of Chi3L1 and Chi3L2 in articular cartilage from femoral
heads of patients undergoing joint replacement. Protein levels were determined
by western blotting using speciﬁc antisera. The intensity of bands was deter-
mined densitometrically and normalized to a Chi3L1 or Chi3L2 standard in-
cluded in each blot. Cartilage specimens are grouped into those showing macro-
scopic lesions and lesion-free specimens. The lines represent the mean for each
data set.
Conclusions: The increased production of stress response pro-
teins associated with tissue repair and wound healing by chon-
drocytes suggests that they attempt a repair response similar to
that described in other connective tissues. The induction of the
chi-lectin Chi3L2 is part of this stress response. Its presence in
articular cartilage with early signs of degeneration suggests that
Chi3L2 is produced in response to changes in the matrix environ-
ment and thus could be a useful indicator for the diagnosis and
progression of cartilage erosion.
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Purpose: Our previous study demonstrated that partial inactivation
of Pitx1 gene led to a progressive formation of OA-like lesions in
aging Pitx1+/- mice. To investigate whether Pitx1 plays a role in
human osteoarthritis pathogenesis, we analyzed the expression
level of Pitx1 in knee cartilage of OA patients and age- and gender-
matched control subjects. We observed that Pitx1 mRNA and
protein levels were signiﬁcantly down-regulated in OA patients.
The goals of this study are: 1) to elucidate the mechanisms
responsible for the down-regulation of Pitx1 in osteoarthritis and
2) to identify genes affected by the loss of Pitx1.
Methods: To look for possible mutations, genomic DNA from OA
patients and normal subjects were isolated and 10 kb fragment
upstream of Pitx1 initiation transcription site was sequenced. A
region in Pitx1 promoter, where a SNP was found in the core of an
E2F-response element, was used as bait for DNA pull-down assay
followed by mass spectrometry analysis. The proteins which were
identiﬁed by this method were challenged in different assays either
to conﬁrm their presence in the protein-DNA complex (by EMSA,
ChIP and co-immunoprecipitation), to analyze their expression
level (by RT-PCR and immunohistochemistry) or to determine their
ability to affect the regulation of Pitx1 (by transfection assays
with luciferase). Finally, to identify potential transcriptional targets
of Pitx1, expression level of candidate genes were analysed by
RT-PCR using either mouse model or mRNA isolated from normal
and OA chondrocytes.
Results: No mutation was found in human Pitx1 promoter to
be signiﬁcantly associated with osteoarthritis. Nevertheless, a
SNP, which was found in an E2F-response element caught our
attention since E2F1 was known to up-regulate Pitx1. The mass
spectrometry analysis allowed us to identify a repressor complex
constituted of PHB1, PHB2 and BCoR, which are also known to
act as co-repressors. The presence of BCoR tethered to this E2F
response element was demonstrated by EMSA and ChIP assays.
Since BCoR has never been shown to form a complex with PHB1,
we conﬁrmed this result by co-immunoprecipitation using nuclear
extracts from chondrocytes of OA patients. By transfection assays
using luciferase reporter gene, we were able to show that the
complex formed of PHB1, PHB2 and BCoR is functionally capable
of down-regulating the expression of Pitx1. Using mRNA isolated
from Pitx1+/+, Pitx1-/- mice and OA patients, we were able to
show that knockdown of Pitx1 expression resulted in up-regulation
of PPAR-gamma, Parp1, Extl3 and Reg1B.
Conclusions: We discovered a new complex formed of PHB1,
PHB2 and BCoR which are tethered to an E2F-response element
and able to down-regulate the expression of Pitx1 in chondrocytes
of OA patients. In pre-OA chondrocytes, the nuclear accumulation
of PHB1 could be a primary mechanism leading to OA onset.
The subsequent loss of Pitx1 expression could contribute to the
progression of OA via the up-regulation of PPAR-gamma, Parp1,
Extl3 and Reg1B.
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Purpose: ADAMTS4 and ADAMTS5 are accepted as the main
aggrecanases involved in OA cartilage degradation but the rela-
tive contribution of each enzyme in human disease is still under
debate. Mouse knockout studies have conﬁrmed the importance
of ADAMTS5 in cartilage degradation while ADAMTS4 is generally
associated to OA due to its strong upregulation by IL1β. SiRNA ex-
periments indicate that both aggrecanases participate in cartilage
degradation in human explants. The present study seeks to further
elucidate the role of both aggrecanases in cartilage degradation
using selective pharmacological inhibitors.
Methods: Induction of ADAMTS4 and ADAMTS5 expression by
different cytokines was studied in cartilage explants using RT-
QPCR. Cartilage degradation was induced in human explants
by OSM+TNFα or OSM+ IL1β and the role of individual aggre-
canases was evaluated by pharmacological inhibition using com-
pounds which were synthesised and selected for high selectivity
for ADAMTS4 or ADAMTS5.
